Top 50 Medical Device VC Funds & Investors in Australia (June 2026)
For AI agents: Short investor table (Markdown), Detailed investor list (Markdown)
| Investor | Relevant Deals | Geography | Stage | Focus | Round Size |
|---|---|---|---|---|---|
|
Brandon Capital
VC Fund
|
8 | Australia, United Kingdom, United States | Series A, Seed, Series B | Biotechnology, Health Care, Medical | $673k–$81M |
|
Artesian VC
VC Fund
|
7 | Australia, United States, Hong Kong | Seed, Series A, Pre-Seed | Software, Artificial Intelligence, Health Care | $40k–$15M |
|
Medical Research Commercialisation Fund (MRCF)
VC Fund
|
6 | Australia, United States, United Kingdom | Series A, Seed, Series B | Biotechnology, Health Care, Medical | $1.3M–$16M |
|
Uniseed
VC Fund
|
4 | Australia, United States, United Kingdom | Series A, Seed, Series B | Biotechnology, Health Care, Manufacturing | $471k–$22M |
|
Melbourne Angels
VC Fund
|
4 | Australia, United States, New Zealand | Angel, Seed | Biotechnology, Information Technology, Energy | $34k–$1.3M |
|
Sydney Angels
VC Fund
|
4 | Australia, United States | Seed, Angel, Pre-Seed | Software, SaaS, Health Care | $120k–$1.5M |
|
Breakthrough Victoria
VC Fund
|
4 | Australia, United States, Philippines | Seed, Series A | Health Care, Manufacturing, Biotechnology | $708k–$36M |
|
Significant Ventures
VC Fund
|
3 | Australia | Seed, Series A | Manufacturing, Software, Health Care | $67k–$8.2M |
|
South Australian Venture Capital Fund
VC Fund
|
2 | Australia | Seed, Series B | Health Care, Biotechnology, Internet of Things | $1M–$24M |
|
Global Health Investment Fund (GHIF)
VC Fund
|
2 | United States, India, Austria | Series B, Series C | Health Care, Biotechnology, Medical Device | $4.5M–$18M |
|
Uniseed Ventures
VC Fund
|
2 | Australia, United States, United Kingdom | Series A, Seed | Biotechnology, Health Care, Manufacturing | $381k–$16M |
|
Regal Funds Management
VC Fund
|
2 | Australia, United States, United Kingdom | Convertible Note, Series B | Software, Financial Services, FinTech | $1.7M–$26M |
|
Avicella Capital
VC Fund
|
1 | Australia | Series A, Series B | Therapeutics, Medical, Robotics | $3.1M–$25M |
|
Terra Rossa Capital
VC Fund
|
1 | Australia | Series A, Series B | Health Care, Biotechnology, Medical Device | |
|
CoAct Capital
VC Fund
|
1 | Australia, New Zealand | Series A, Seed, Series B | Software, Information Technology, SaaS | $5.8M–$14M |
|
OneVentures
VC Fund
|
1 | Australia, United States, Israel | Series A, Debt Financing | Software, Health Care, Biotechnology | $1M–$20M |
|
PsyMed Ventures
VC Fund
|
1 | United States, Canada, Israel | Seed, Series A | Health Care, Biotechnology, Medical | $100k–$70M |
|
Blackbird Ventures
VC Fund
|
1 | Australia, United States, New Zealand | Seed, Series A, Pre-Seed | Software, Artificial Intelligence, SaaS | $34k–$35M |
|
Powerhouse Ventures
VC Fund
|
1 | United States, Australia, United Kingdom | Seed, Series A, Pre-Seed | Software, Energy, Solar | $1.1M–$30M |
|
Transition Level Investments
VC Fund
|
1 | Australia, United States | Seed, Pre-Seed, Series A | SaaS, Software, Health Care | $60k–$2.4M |
|
Brisbane Angels
VC Fund
|
1 | Australia, United States, New Zealand | Seed, Angel, Pre-Seed | Software, Biotechnology, Machine Learning | $120k–$1.3M |
|
Ramsay Health Care
VC Fund
|
1 | Australia | Series A | Medical, Health Care, Medical Device | |
|
Venture-Store Pty Ltd
VC Fund
|
1 | Australia | Seed | Wellness, Blockchain, Health Care | |
|
SFC Capital
VC Fund
|
1 | United Kingdom, United States, Canada | Pre-Seed, Seed | Software, Artificial Intelligence, Information Technology | $162k–$2.2M |
|
Versant Ventures
VC Fund
|
1 | United States, Switzerland, Canada | Series A, Series B, Series C | Biotechnology, Health Care, Medical | $4.7M–$108M |
|
Anova Capital
VC Fund
|
1 | China, Australia | Series A, Seed | Education, Rental, Travel | |
|
Upswell Ventures
VC Fund
|
1 | Australia, Canada, United Kingdom | Seed, Series A | Software, Developer Tools, Apps | $539k–$13M |
|
Development Bank of Wales
VC Fund
|
1 | United Kingdom, Australia, United States | Seed, Debt Financing | Software, Health Care, Biotechnology | $18k–$3.7M |
|
HealthCare Ventures
VC Fund
|
1 | United States, Australia, United Kingdom | Series B, Series A, Series C | Biotechnology, Health Care, Pharmaceutical | $4.4M–$50M |
|
Playford Capital
VC Fund
|
1 | Australia | Series A, Series B | Health Care, Biotechnology, Medical Device | |
|
CP Ventures
VC Fund
|
1 | Australia, United States, India | Seed, Pre-Seed | Software, Artificial Intelligence, Machine Learning | $350k–$3.9M |
|
Grand Challenges Canada
VC Fund
|
1 | Canada, United States, Australia | Grant, Seed, Debt Financing | Health Care, Medical Device, Biotechnology | $100k–$3.3M |
|
BridgeLane Capital
VC Fund
|
1 | Australia, Germany, United States | Seed, Series A | Software, Real Estate, Financial Services | $673k–$6M |
|
Archangel Ventures
VC Fund
|
1 | Australia, United States, Philippines | Seed, Pre-Seed, Series A | Software, SaaS, Artificial Intelligence | $100k–$22M |
|
Sirius Capital
VC Fund
|
1 | China, Australia | Series A, Seed, Angel | Artificial Intelligence, Robotics, Video | $7M–$50M |
|
Victoria University of Wellington
VC Fund
|
1 | Australia | Seed | Health Care, Biotechnology, Medical Device | |
|
Starfish Ventures
VC Fund
|
1 | United States, Australia, Philippines | Series A, Series B | Software, Enterprise Software, Internet | $2M–$18M |
|
Right Click Capital
VC Fund
|
1 | Australia, Singapore, United States | Seed, Series A | Software, SaaS, Information Technology | $200k–$16M |
|
UniSA Ventures
VC Fund
|
1 | Australia | Seed | Software, Health Care, Biotechnology | |
|
Skip Capital
VC Fund
|
1 | Australia, United States, Canada | Seed, Series A, Series B | Software, Artificial Intelligence, SaaS | $1.3M–$100M |
|
VU Venture Partners
VC Fund
|
1 | United States, Colombia, India | Seed, Series A | Software, Health Care, Machine Learning | |
|
Khosla Ventures
VC Fund
|
1 | United States, India, United Kingdom | Series A, Series B, Seed | Software, Artificial Intelligence, Health Care | $2M–$100M |
|
Fund WA
VC Fund
|
1 | Australia | Seed, Series A | Medical, Health Care, Manufacturing | |
|
Horizons Ventures
VC Fund
|
1 | United States, United Kingdom, Canada | Series A, Series B, Seed | Biotechnology, Software, Artificial Intelligence | $1M–$110M |
|
Microsoft for Startups
VC Fund
|
1 | United States, India, Canada | Seed, Pre-Seed | Software, Information Technology, SaaS | |
|
SOSV
VC Fund
|
1 | United States, India, United Kingdom | Seed, Convertible Note, Pre-Seed | Biotechnology, Health Care, Software | |
|
Future of Healthcare Fund - Australian Unity
VC Fund
|
1 | Australia | Series A | Health Care, Medical Device | |
|
Monash Ventures
VC Fund
|
1 | Australia, Philippines, United States | Pre-Seed | Medical, Health Care, Biotechnology | |
|
SPRIM Global Investments
VC Fund
|
1 | France, Australia, United States | Series A, Debt Financing | Biotechnology, Health Care, Medical Device | $500k–$26M |
|
StreShi
VC Fund
|
1 | Australia, United States | Seed | Bitcoin, FinTech, Medical | |
| Access all 123 VC funds in Australia Medical Device startups. | |||||
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Investor list
Brandon Capital invests in the most promising biomedical opportunities that have the potential to improve the lives of patients.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series A, Seed, Series B
- Geography: Australia, United Kingdom, United States
Investor stats
- Total investments: 61
- Round size: Seed $673k–$6.7M; Series A $4.9M–$81M; Series B $6.4M–$68M
- Lead/follow: 31% lead, 69% follow
- Last fund: May invest from a new fund soon — raised $210M in 2019
Portfolio highlights
- Ena Respiratory — Ena Respiratory is a biotechnology company seeking to transform the treatment and prevention of respiratory infections and the effectiveness of vaccines.Ena Respiratory novel, synthetic Toll-like receptor 2 (TLR2) receptor agonists have been shown to activate the innate immune system in the respiratory tract and prevent viral and bacterialdissemination to the lungs.
- Allay Therapeutics — SUPPORTING PATIENTS THROUGH EVERY PHASE OF RECUPERATION The first technology designed to deliver weeks of localized pain management
- Pheon Therapeutics — Pheon Therapeutics is an Antibody-Drug Conjugate (ADC) specialist that creates ADCs for a variety of difficult-to-treat cancers. Its lead program is a first-in-class ADC against a novel target that is highly expressed in solid tumors across a broad range of hard-to-treat cancer types.The company was founded in 2022 and is based in London,England.
Artesian Capital Management is an alternative investments management company, which was spun out of ANZ Banking Group's capital markets business in 2004, with backing from ANZ Private Equity. Artesian's founding partners, purchased ANZ's stake in 2005. The company has subsequently been fully owned by partners and staff. Since 2004,Artesian has managed specialised funds focused on credit arbitrage and relative-value strategies across global financial markets. In 2008, while continuing to manage credit relative value investment strategies from its New York, London and Singapore offices, Artesian began to make principal investments in seed/early-stage ventures from its offices in Sydney, Melbourne and Shanghai. In 2011, Artesian launched the first of its early stage venture capital funds and now manages AUD +255m. Artesian's VC strategy is to partner with best of breed accelerators, incubators, angel groups and university programs. In 2017, Artesian launched its China VC Fund with a USD 50m cornerstone investment industry super fund Hostplus. Artesian will soon launch a Southeast Asia VC Fund.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Health Care
- Stage:Seed, Series A, Pre-Seed
- Geography: Australia, United States, Hong Kong
Investor stats
- Total investments: 227
- Round size: Seed $120k–$5M; Pre-Seed $40k–$1.5M; Series A $2.3M–$15M
- Lead/follow: 34% lead, 66% follow
- Last fund: Likely still investing — fund raised in 2023
Portfolio highlights
- CUZIN — Providing a surprisingly human shopping experience. Trusted and secure. Millions of domains to choose from.
- Andromeda Robotics — At Andromeda, our personalised robot companions are helping Australian aged care teams bring joy and connection to residents to improve wellbeing.
- Infiction labs — SPARC 1.2 is a solar panel robotic cleaning system designed and developed by Infiction Labs Pvt Ltd for commercial solar plants.
Medical Research Commercialisation Fund (MRCF) provides dedicated, investment funding to support the commercialisation of early-stage medical research discoveries that originate from its member institutes. The collaborative nature of the MRCF seeks to foster best practice in the commercialisation of medical innovations.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series A, Seed, Series B
- Geography: Australia, United States, United Kingdom
Investor stats
- Total investments: 25
- Round size: Series A $1.3M–$13M; Series B $6.4M–$16M
- Lead/follow: 28% lead, 72% follow
Portfolio highlights
- Denteric — Denteric is developing a vaccine based on research conducted at the University of Melbourne, with collaborative support from CSL Limited, to fight the disease and will receive the money in three parts each year from 2019 to 2021.
- Currus Biologics — Currus Biologics is a biotechnology company that develop CAR-T cell therapies for the treatment of solid tumour cancers.
- Azura Ophthalmics — Azura Ophthalmics is a clinical-stage company that develops an innovative portfolio of compounds to advance treatments for MGD, the leading cause of DED. By targeting the root cause of MGD, Azura brings the promise of improved health and well-being to millions of people worldwide who suffer from MGD and other ocular surface diseases where treatmentoptions are currently lacking. Azura is underpinned by an experienced management team with an established track record of successfully developing and commercializing novel treatments for ocular surface diseases. The company headquartered in Tel Aviv-Yafo, Israel with operations in Australia and the U.S.
Uniseed was established in October 2000 as a $20 million joint venture between the University of Melbourne (UM) and the University of Queensland (UQ). This proof of concept fund (Fund-1) operated with significant input and support from the commercialization offices of the two universities (UniQuest and Melbourne Ventures Limited), with staff ofthese organizations making up the majority of the Investment Committee and leading due diligence and management of most investment opportunities. Over 20 investments, typically of $250,000 - $500,000 were made from this fund.A new $40 million venture fund (Fund-2) ran from 2005-15, with the addition of a third leading university, the University of New South Wales, and a major private institutional investor, the Westscheme superannuation fund. The founding universities (UQ & UM) also committed further funds. Australian Super took over Westscheme's essets and commitments in July 2011.With the start of Fund-2, an independent management team was established, consisting of the CEO and three Investment Managers; one at each university catchment. The Investment Committee was restructured, with dedicated committees established for biotechnology or other technologies. The nominal investment limit was increased to $2.5 million to allow participation in follow-on funding rounds so as to preserve Uniseed's equity position.On 1 November 2015, Uniseed started its third and largest fund (Fund-3) with the addition of the University of Sydney and the CSIRO to the Universities of Queensland, Melbourne and NSW. This followed three high profile exits in the preceding 14 months (Fibrotech; Spinifex & Hatchtech). Each of the five partners committed $10 million over 10 years to the new fund (total fund $50 million).Uniseed’s partner research organisations spent nearly $4 billion on research, making up over 40% of the total research spend at 67 research organisations in Australia. Together, these organisations accounted for nearly 500 invention disclosures (34% of total) and 500 new registered IP rights filed (45% of total) over the same period(2013 National Survey of Research Commercialisation). Unlike private venture capital funds, Uniseed is dedicated to the needs of its research partners, and committed to servicing them consistently over the long term, irrespective of the short term conditions in external capital markets. It works in very close partnership with the research partner commercialisation companies and staff, providing a valuable adjunct to the capabilities these companies and staff provide. They in turn provide a best-practice commercialisation service tailored to their respective organisations. These companies are able to leverage to great effect the scale of operation and expertise of the Uniseed network.The fund is run with commercial discipline, ensuring independence and financial rigor in its investment decision-making processes. Success is measured by a balance of return on investment (including the flow of funds for research to further the commercialisation of intellectual property generated within the research partner catchments), the establishment of viable start-up companies, the generation of research income for research partners and the improvement of partner commercialisation processes.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Manufacturing
- Stage:Series A, Seed, Series B
- Geography: Australia, United States, United Kingdom
Investor stats
- Total investments: 84
- Round size: Seed $600k–$3.5M; Series A $1.6M–$16M; Series B $471k–$22M
- Lead/follow: 23% lead, 77% follow
- Last fund: May invest from a new fund soon — last raise in 2017
Portfolio highlights
- Lucia Bio — Lucia Bio is a biotechnology company that focuses on developing Syk inhibitors that help in the treatment of immunological diseases.
- Tiny Bright Things — Melbourne-based company Tiny Bright Things was cofounded in 2020 by long-time research collaborators Ray Dagastine and Chris Bolton. We invented Halo microscopy to transform the way researchers and manufacturers look at small or transparent things. This helps manufacturers in areas like agrichemicals and pharmaceuticals (where the size and shape ofpowders are critical) and researchers at every stage of discovery— particularly in nanotechnology (where samples are especially tiny) and life sciences (where samples are often also transparent).
- Kinoxis Therapeutics — Developing novel therapeutics for social dysfunction and substance use disorders.
Melbourne Angels was formed in Melbourne, Australia in early 2007. Melbourne Angels is the leading group of private investors in Victoria who actively invest in early stage and growth technology companies.The group has a strong and experienced core of members that generate deal flow, are experienced in evaluation of business propositions and actas mentors for the other members and the entrepreneurs. The members vary in age, gender, ethnicity, profession and type of experience. All members have experience of success at being entrepreneurial.This award winning group is consistently one of the most active startup investors in the country.
Show more...Investment focus
- Industry: Biotechnology, Information Technology, Energy
- Stage:Angel, Seed
- Geography: Australia, United States, New Zealand
Investor stats
- Total investments: 42
- Round size: Seed $34k–$1.3M; Angel $219k–$918k
- Lead/follow: 52% lead, 48% follow
Portfolio highlights
- Emanda — Emanda App helps business advisory firms and companies determine business value, auto-generate data rooms, set goals, and track progress daily via AI-driven tools.
- Auric Essentials — Auric - The Power of Scent. Revolutionise your well-being with Auric. Discover our state-of-the-art AI-powered AromaSphere diffuser and app, designed to personalise your aromatherapy experience.
- Bitwise Agronomy — Bitwise Agronomy uses AI to analyze crop video footage and provide growers with insights into crop health, growth, and yield potential.
Sydney Angels is a not-for-profit angel investment membership organisation. Since our establishment in 2008, they have stayed true to our mission of supporting the early-stage ecosystem by running processes and events that connect our investing members with promising early-stage companiesThey believe that encouraging smart investment in startupcompanies will benefit both our members’ portfolios and Australia’s emergent innovation economy.They see this as the ultimate win-win situation. Sydney Angels is led by an elected committee of ten volunteers who meet weekly. It is supported by an operations manager and alliance partners.
Show more...Investment focus
- Industry: Software, SaaS, Health Care
- Stage:Seed, Angel, Pre-Seed
- Geography: Australia, United States
Investor stats
- Total investments: 94
- Round size: Seed $120k–$1.3M; Angel $130k–$890k; Pre-Seed $337k–$1.5M
- Lead/follow: 37% lead, 63% follow
- Last fund: May invest from a new fund soon — last raise in 2016
Portfolio highlights
- Quizling — Quizling is an educational app that allows its users to make quick quizzes on their iPhone or iPad. Its users have the ability to plug their iPhone or iPad into their smart board or digital projector and challenge their class.Quizling is designed for teachers, students, and classrooms. Its aim is to make a teacher’s life easier, a student’slearning more interesting and challenging, and to help make the classroom a fun and engaging place. It can be used to preview a topic and check prior learning or before a test. Students also have the opportunity to make their own quizlings and challenge each other.Quizling was launched in 2012.
- ExtrasJar — Swap health insurance premiums for balanced investments and get access to your funds when using health services.
- Mary Technology — Generate detailed chronologies from documents in minutes with Mary Technology. Achieve 90%+ time reduction and ensure 99%+ accuracy. Try for free.
The Breakthrough Victoria Fund is a $2 billion investment by the Victorian Government to drive investment in research and innovation.
Show more...Investment focus
- Industry: Health Care, Manufacturing, Biotechnology
- Stage:Seed, Series A
- Geography: Australia, United States, Philippines
Investor stats
- Total investments: 48
- Round size: Seed $708k–$7.1M; Series A $1.8M–$36M
- Lead/follow: 58% lead, 42% follow
Portfolio highlights
- World View Enterprises — World View sets the standard for stratospheric exploration via remote sensing, C4ISR and asset monitoring via stratospheric balloons, along with future space tourism and research and education offerings.
- RayGen — We're powering the future with low cost, high efficiency solar power technology and renewable energy storage. Contact us for more details today.
- Conflux Technology — Conflux Technology is a new generation of heat exchangers made by metal additive manufacturing (3D printing).
Significant Ventures is an early-stage venture capital fund backing transformative technologies and the ambitious founders behind them.Founded by the Hindmarsh family, Significant Ventures invests in deep tech, applied science and research-driven innovation emerging from Australia’s leading universities and research institutions. The fundcombines capital with active, hands-on support—helping early-stage companies shape their strategy, attract talent, and access follow-on funding.With a network of expert operators, advisors and institutional partners, Significant Ventures focuses on turning high-potential ideas into globally scalable businesses. The team works closely with founders across sectors including life sciences, climate tech, AI, education and advanced manufacturing.Driven by a commitment to impact, collaboration and long-term value creation, Significant Ventures exists to build the next generation of high-growth companies that will lead Australia’s innovation economy
Show more...Investment focus
- Industry: Manufacturing, Software, Health Care
- Stage:Seed, Series A
- Geography: Australia
Investor stats
- Total investments: 26
- Round size: Seed $67k–$5M; Series A $4.5M–$8.2M
- Lead/follow: 50% lead, 50% follow
Portfolio highlights
- Earthodic — Earthodic is an Australian materials science company creating functional biobased coatings. Paperbarc by Earthodic is a biobased water-resistant coating for pulped or paper products. It has better water-resistance than wax coatings, more sustainable and circular than plastic coatings. Repulpable. Re
- Hearables 3D — Scale your custom-fit volumes and solve dental lab technician shortage with AI and automation solutions.
- Visionary Machines — Superior perception for next-generation autonomy
South Australian Venture Capital Fund - helping build dynamic and innovative South Australian startups / scaleups and accelerate their growth to a national and global scale.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Internet of Things
- Stage:Seed, Series B
- Geography: Australia
Investor stats
- Total investments: 13
- Round size: Seed $1M–$12M; Series B $13M–$24M
- Lead/follow: 15% lead, 85% follow
Portfolio highlights
- Ferronova — Ferronova is a medical device company that offers imaging and surgery products.
- Seonix Bio — Seonix Bio is dedicated to helping health professionals, individuals and researchers understand glaucoma risk using genetics.
- Pearler.AI — Pearler gives your team super powers to respond fast to RFP, RFI, RFQ, Security, Cyber, Risk & Grant Questionnaires.
The Global Health Investment Fund (GHIF) is a $108 million social impact investment fund designed to provide financing to advance the development of drugs, vaccines, diagnostics and other interventions against diseases that disproportionately burden low- and middle-income countries. GHIF supports late-stage innovations for public health challengessuch as malaria, pre-eclampsia, cholera, HIV and river blindness, with an emphasis on infectious diseases and maternal/infant health issues that cause significant morbidity and mortality in resource-limited settings. GHIF may also make investments that improve or expand access to existing products—such as developing pediatric formulations of approved therapeutics or improving the stability of widely-used global health vaccines.As an investment fund with a limited time-horizon, GHIF seeks opportunities that have a high probability of successful commercialization within two or three years. Products with “dual market” potential are of greatest interest; i.e., those that will have a clear impact on public health in developing countries but also have value in high-income countries. High-volume / low-margin products, such as essential vaccines, are also of significant interest.GHIF employs a range of investment structures including mezzanine debt, convertible debt, preferred equity and project financing with an average investment target of approximately $10 million per project. Each GHIF project must advance the Fund’s social impact objectives and demonstrate the ability to achieve commercial success.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical Device
- Stage:Series B, Series C
- Geography: United States, India, Austria
Investor stats
- Total investments: 18
- Round size: Series B $7.5M–$18M; Series C $4.5M–$14M
- Lead/follow: 39% lead, 61% follow
- Last fund: May invest from a new fund soon — raised $108M in 2012
Portfolio highlights
- PATH — We are a global team of innovators working to accelerate health equity so all people and communities can thrive.
- CXL Ophthalmics — CXLO is developing a minimally invasive treatment for an ectatic corneal disease that can bring early intervention to millions of patients globally.
- Themis Bioscience — Themis Bioscience is a start-up biotechnology company developing vaccines to prevent infectious diseases. The company’s development focus is primarily concentrated on emerging and specialist indications, advancing promising vaccines from preclinical to late-stage clinical development phases. We aim to exploit the increasing licensing andacquisition trend to generate value by developing and partnering our technology programs and vaccine candidates. It is our mission to establish Themis as a first class biotech development boutique and to become a preferred licensing partner for leading biotech and pharmaceutical companies.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Uniseed was established in October 2000 as a $20 million joint venture between the University of Melbourne (UM) and the University of Queensland (UQ). This proof of concept fund (Fund-1) operated with significant input and support from the commercialization offices of the two universities (UniQuest and Melbourne Ventures Limited), with staff ofthese organizations making up the majority of the Investment Committee and leading due diligence and management of most investment opportunities. Over 20 investments, typically of $250,000 - $500,000 were made from this fund.A new $40 million venture fund (Fund-2) ran from 2005-15, with the addition of a third leading university, the University of New South Wales, and a major private institutional investor, the Westscheme superannuation fund. The founding universities (UQ & UM) also committed further funds. Australian Super took over Westscheme's essets and commitments in July 2011.With the start of Fund-2, an independent management team was established, consisting of the CEO and three Investment Managers; one at each university catchment. The Investment Committee was restructured, with dedicated committees established for biotechnology or other technologies. The nominal investment limit was increased to $2.5 million to allow participation in follow-on funding rounds so as to preserve Uniseed's equity position.On 1 November 2015, Uniseed started its third and largest fund (Fund-3) with the addition of the University of Sydney and the CSIRO to the Universities of Queensland, Melbourne and NSW. This followed three high profile exits in the preceding 14 months (Fibrotech; Spinifex & Hatchtech). Each of the five partners committed $10 million over 10 years to the new fund (total fund $50 million).Uniseed’s partner research organisations spent nearly $4 billion on research, making up over 40% of the total research spend at 67 research organisations in Australia. Together, these organisations accounted for nearly 500 invention disclosures (34% of total) and 500 new registered IP rights filed (45% of total) over the same period(2013 National Survey of Research Commercialisation). Unlike private venture capital funds, Uniseed is dedicated to the needs of its research partners, and committed to servicing them consistently over the long term, irrespective of the short term conditions in external capital markets. It works in very close partnership with the research partner commercialisation companies and staff, providing a valuable adjunct to the capabilities these companies and staff provide. They in turn provide a best-practice commercialisation service tailored to their respective organisations. These companies are able to leverage to great effect the scale of operation and expertise of the Uniseed network.The fund is run with commercial discipline, ensuring independence and financial rigor in its investment decision-making processes. Success is measured by a balance of return on investment (including the flow of funds for research to further the commercialisation of intellectual property generated within the research partner catchments), the establishment of viable start-up companies, the generation of research income for research partners and the improvement of partner commercialisation processes.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Manufacturing
- Stage:Series A, Seed
- Geography: Australia, United States, United Kingdom
Investor stats
- Total investments: 57
- Round size: Seed $381k–$4.2M; Series A $1.3M–$16M
- Lead/follow: 12% lead, 88% follow
- Last fund: May invest from a new fund soon — raised $14M in 2017
Portfolio highlights
- BioScout — Welcome to BioScout, your partner in revolutionizing the agriculture industry with cutting-edge automated disease detection technology for crop growers and viticulture.
- Ferronova — Ferronova is a medical device company that offers imaging and surgery products.
- Morse Micro — Morse Micro is a fast-growing wireless integrated circuit solutions company that is reinventing Wi-Fi for the Internet of Things (IoT). The company was founded by Wi-Fi pioneers and innovators, Michael De Nil and Andrew Terry, joined by the original Wi-Fi inventor Prof. Neil Weste and wireless industry veterans, whose teams designed Wi-Fi chipsinto billions of smartphones. Headquartered in Australia with offices in China and the U.S., Morse Micro’s strong and diverse system team, portfolio of IP and patents, enables Wi-Fi HaLow connectivity across the complete IoT ecosystem, from surveillance systems and access control to industrial automation and mobile devices, allowing connected devices to reach farther. www.morsemicro.com
Regal Funds Management was founded in 2004 by Andrew and Philip King. Regal utilises a long/short investment strategy and performs investment management and investment advisory services to a number of Australian Unit Trusts and Cayman Island Companies.
Show more...Investment focus
- Industry: Software, Financial Services, FinTech
- Stage:Convertible Note, Series B
- Geography: Australia, United States, United Kingdom
Investor stats
- Total investments: 77
- Round size: Series B $7M–$26M; Convertible Note $1.7M–$17M
- Lead/follow: 32% lead, 68% follow
- Last fund: Likely still investing — raised $54M in 2022
Portfolio highlights
- Send Payments — Seamless cross-border payments for people, businesses and enterprises. Make fast, secure and reliable payments in 100+ currencies to over 170 countries.
- Firmus Technologies —
- Iondrive — Iondrive is an exploration company that provides metals. They offer products that include gold, silver, copper, and other metals. They provide services for industrial use.
Avicella Capital is to identify and finance commercial ventures that ethical and creative entrepreneurs have created to enhance patient outcomes and raise the standard of healthcare.
Show more...Investment focus
- Industry: Therapeutics, Medical, Robotics
- Stage:Series A, Series B
- Geography: Australia
Investor stats
- Total investments: 3
- Round size: Series A $3.1M–$25M
- Lead/follow: 33% lead, 67% follow
Portfolio highlights
- Faeth Therapeutics — Home | Faeth
- Kinoxis Therapeutics — Developing novel therapeutics for social dysfunction and substance use disorders.
- Convergence Medical Robotics — Convergence Medical Robotics is a Brisbane-based pre-clinical medical robotics company making arthroscopy better through the invention of the V01 Robot. It solves the complexity of arthroscopy by creating the world's first arthroscopic robot.
Terra Rossa Capital Pty Ltd operates as a venture capital fund. The Company invests in life science companies. Terra Rossa Capital serves clients in Australia.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical Device
- Stage:Series A, Series B
- Geography: Australia
Investor stats
- Total investments: 2
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Signostics — Signostics produces Biotech medical devices. Their flagship product, Signos, allows healthcare professionals to use ultrasound in their clinical practice. It offers ultrasound platform technology that clinicians can place in their pocket or wear around their neck like a stethoscope. Just as handheld devices transformed the business world, it isanticipated the Signos will change the way healthcare professionals practice medicine.Signostics was established in Adelaide, Australia in 2005 and expanded into the U.S. in 2008, dedicated to developing fast and affordable pointâ€ofâ€care medical devices. The company launched its first product into the veterinarian market in January 2009 andgained regulatory approvals to enter the human medical device market for the United States, Europe, and Australia in May 2009. Signostics has offices in Palo Alto, California and Adelaide, South Australia.
Co:Act is an investment partnership of experienced venture investors with a network of founders.
Show more...Investment focus
- Industry: Software, Information Technology, SaaS
- Stage:Series A, Seed, Series B
- Geography: Australia, New Zealand
Investor stats
- Total investments: 9
- Round size: Series A $5.8M–$14M
- Lead/follow: 33% lead, 67% follow
Portfolio highlights
- Diraq — Diraq is building quantum computers using modified silicon transistors, the technology best suited to reaching utility scale, where value outweighs cost.
- EatClub — EatClub shows you nearby restaurants, with spare tables, offering last minute deals. Receive up to 50% off your bill (including drinks!)
- Hearables 3D — Scale your custom-fit volumes and solve dental lab technician shortage with AI and automation solutions.
OneVentures is a later-stage venture capital firm focused on scaling Technology and Healthcare companies through growth equity and credit. The firm's role extends far beyond investment, as the firm actively guides companies toward achieving their next critical milestones. By leveraging decades of global experience and operational expertise,OneVentures accelerates growth and helps shape the future of its portfolio companies.A global growth focus drives their investment selection, with their current portfolio including companies with truly innovative products tackling multi-billion-dollar problems, from needle-free vaccinations to virtual communications to adaptive e-learning.
Show more...Investment focus
- Industry: Software, Health Care, Biotechnology
- Stage:Series A, Debt Financing
- Geography: Australia, United States, Israel
Investor stats
- Total investments: 77
- Round size: Series A $1.5M–$20M; Debt Financing $1M–$6.7M
- Lead/follow: 48% lead, 52% follow
- Last fund: Likely still investing — raised $145M in 2022
Portfolio highlights
- Vaxxas — Vaxxas develops and commercializes needle-free vaccine delivery system. Vaxxas was incorporated in 2011 and is based in Brisbane, Australia.
- Kira Biotech — Kira Biotech is an emerging Australian biotechnology company developing novel immunomodulatory compounds for the treatment of immune system disorders. Its lead candidate, KB312, is a first-in-class, selective, immune-cell depleting monoclonal antibody which targets activated immune cells and aims to restore homeostasis through induction of immunetolerance. Kira Biotech has attracted venture capital funding and is progressing KB312 through preclinical development and phase 1 clinical trials with a team of drug development experts led by well-known US-based rheumatologist and immunologist, Dr Dan Baker.
- Vertero — Axial Therapeutics is a biotechnology company fundamentally changing the treatment of neurological diseases and disorders by harnessing groundbreaking science in the microbiome-gut-brain axis.
We are a community focused fund and syndicate investing in frontier mental health: psychedelics, neurotech, precision psychiatry, digital therapeutics, holistic medicine, metabolic psychiatry, digital health, and artificial intelligence.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical
- Stage:Seed, Series A
- Geography: United States, Canada, Israel
Investor stats
- Total investments: 24
- Round size: Seed $100k–$21M; Series A $4.8M–$70M
- Lead/follow: 0% lead, 100% follow
- Last fund: Likely still investing — raised $25M in 2022
Portfolio highlights
- Aerska — Aerska develops targeted RNA medicines to treat brain diseases. By silencing genes that cause harm, we can preserve the minds and memories of those we love.
- Sanmai — Sanmai is a neurotechnology company developing non-invasive ultrasound neurotherapeutics for mental health and neurological disorders
- Jimini Health — Jimini’s mission is to radically improve the efficacy of mental health care across the world. Jimini has developed a novel care model that combines teletherapy sessions with personalized AI support. With Jimini, your therapy care team includes your licensed clinician and Sage, your always-available AI therapy assistant, who work together to helpyou achieve your goals.Founded in 2023 by a team of seasoned AI and biotech entrepreneurs, health tech veterans, and psychology researchers, Jimini puts science and tech first, using safe, purpose-built patient-facing technology that works exclusively under clinical oversight and high safety standards.World leaders in psychology designed Jimini’s care model to ensure that every part of the patient's journey is clinically beneficial. Jimini does not believe that LLMs should replace clinicians; rather, AI will help therapists deliver higher-quality care and focus on the most complex parts of their job. Jimini’s care model is first and foremost led by excellent clinicians.Jimini is committed to improving mental health quality and creating radically better, more modern, and clinically efficacious mental health experiences for patients.
Blackbird is a venture capital fund based in Australia and New Zealand. We invest in every type of technology from software to space, unified by the biggest of ambitions.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, SaaS
- Stage:Seed, Series A, Pre-Seed
- Geography: Australia, United States, New Zealand
Investor stats
- Total investments: 311
- Round size: Seed $34k–$7.1M; Pre-Seed $50k–$3M; Series A $3.4M–$35M
- Lead/follow: 40% lead, 60% follow
- Last fund: Likely actively investing — fund raised in 2025
Portfolio highlights
- Sumday — Non - financial accounting software. Start carbon accounting, properly, with the support of your existing advisors
- Fleet Space Technologies — Fleet is an agile, next generation connectivity company. Our mission is to Connect Everything using cutting-edge communications and space technologies to maximise the resource efficiency of human civilisation and enable the next industrial revolution with our free, ubiquitous connectivity platform.
- Gilmour Space Technologies — Gilmour Space is a rocket company in Australia that is developing and launching low-cost small satellite launch vehicles. All orbits, all planets: https://www.gspacetech.com
Powerhouse Ventures backs entrepreneurs building the digital infrastructure for rapid decarbonization.
Show more...Investment focus
- Industry: Software, Energy, Solar
- Stage:Seed, Series A, Pre-Seed
- Geography: United States, Australia, United Kingdom
Investor stats
- Total investments: 58
- Round size: Seed $1.1M–$5.7M; Pre-Seed $1.1M–$1.2M; Series A $6M–$30M
- Lead/follow: 17% lead, 83% follow
Portfolio highlights
- Zeti — Enabling the scale up of real world assets essential to the energy transition by connecting operators and institutional capital through simple, technology powered finance.
- AmpUp — Commercial electric vehicle (EV) charging network solutions made simple for everyone. Easily manage and analyze EV charging data from a single dashboard.
- Sybill AI — Bringing Emotional Intelligence to Video Calls
Founded by Steve Baxter, Transition Level Investments provides equity capital and operational expertise across Seed and Series A rounds to Australian companies. Our team focuses on a company-growth approach, adding value by assisting founders to build their expertise, expand their team, build product, scale locally and globally to position for asuccessful exit. We have a track record of identifying investment opportunities in the Australian market and helping enable global growth.
Show more...Investment focus
- Industry: SaaS, Software, Health Care
- Stage:Seed, Pre-Seed, Series A
- Geography: Australia, United States
Investor stats
- Total investments: 19
- Round size: Seed $875k–$2.4M; Pre-Seed $60k–$1.5M
- Lead/follow: 32% lead, 68% follow
Portfolio highlights
- Go1 — Simplify employee training with one subscription that delivers essential learning from 250+ providers, integrated seamlessly into your HR tech stack.
- Kapiche — Customer intelligence for CX, support and product teams who need to understand their customers accross more than just surveys. Analyze 100% of customer conversations to prevent churn and accelerate growth.
- Clipchamp — Create videos with royalty-free music and stock footage, use video templates, and export in up to 4K video resolution. Get started in-browser or download the Windows app.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Formed in late 2006, the Brisbane Angels Pty Ltd is a large group of private investors who actively invest in early stage technology companies, usually in South East Queensland, Australia. The members are typically active or semi-retired former senior business executives, who apart from financial input can provide much needed value adding toinvestee companies through hands-on management experience and high level business networks.
Show more...Investment focus
- Industry: Software, Biotechnology, Machine Learning
- Stage:Seed, Angel, Pre-Seed
- Geography: Australia, United States, New Zealand
Investor stats
- Total investments: 48
- Round size: Seed $120k–$1.3M; Angel $337k–$629k; Pre-Seed $200k–$1.3M
- Lead/follow: 15% lead, 85% follow
Portfolio highlights
- Giftbee — Giftbee is a B2B gifting marketplace with smart, eco-friendly solutions that enhance value and experience.
- Auric Essentials — Auric - The Power of Scent. Revolutionise your well-being with Auric. Discover our state-of-the-art AI-powered AromaSphere diffuser and app, designed to personalise your aromatherapy experience.
- The Laundry Lady — The Laundry Lady is a mobile laundry service company that offers washing, ironing, pickup, and delivery services.
Ramsay Health Care provides health care services to public and private patients. Its health care services comprise day surgery procedures and complex surgeries, as well as psychiatric care and rehabilitation services. It operates approximately 235 hospitals and day surgery facilities with approximately 25,000 beds in Australia, the United Kingdom,France, Indonesia, Malaysia, Maldives, and Italy. Paul Ramsay founded Ramsay Health Care in 1964. It has its headquarters in Sydney in Australia.
Show more...Investment focus
- Industry: Medical, Health Care, Medical Device
- Stage:Series A
- Geography: Australia
Investor stats
- Total investments: 1
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Harrison.ai — Harrison.ai is a clinician-led healthcare AI company using deep learning to improve the odds of IVF success for thousands of patients. The company leverages deep learning to solve the biggest challenges in healthcare and seeks to improve patient outcomes. It empowers physicians and healthcare providers with customized AI-enabled tools thatintegrate into existing clinical workflows which ultimately lead to improved patient outcomes.Harrison.ai uses the deskside DGX Station for experimentation, research, and development. The company uniquely combines exceptional deep learning expertise with clinical experience to develop and deploy healthcare AI solutions. Harrison.ai’s IVY deep learning model analyzes the full five-day video feed from an embryo scope, helping it surpass the performance of AI tools that provide insights based on still images.Harrison.ai's mission is to continuously innovate and commercialize more efficient and more affordable healthcare products and services to healthcare providers and patients.Harrison.ai was founded in 2018 and is headquartered in Barongarook, Victoria, Australia.
Only a few year ago, it took $ millions to get a tech venture to market; $1m before cutting a line of code, another $1m or so to get v1.0 into customers hands, millions more refining it.That was for a start up. Multiply it times over for a large corporate.Then, assuming it was a product people used/wanted, millions to scale it. If theproduct/market fit wasn't there, millions more to pivot, chase a business model.Today ideas can be conceived, tested, architected, teams added, capabilities assembled, services built, deployed, at scale, globally for a fraction of the cost and time.Venture-Store is founded upon this profound shift: ideas with unicorn scale, potential, shipped to market rapidly, inexpensively, by anyone from anywhere in the world.The scale, sophistication and configurability of tech is fuelling unprecedented innovation throughout business and society. Markets are up for grabs, open to new, better ways of solving problems and creating value for consumers. For entrepreneurs, start ups, corporations and investors the game is changing. Earlier access to new ventures is more important than ever to investment returns.
Show more...Investment focus
- Industry: Wellness, Blockchain, Health Care
- Stage:Seed
- Geography: Australia
Investor stats
- Total investments: 1
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Helfie.ai — Helfie AI is a groundbreaking mobile platform that enables easy, instant and affordable health checks for a wide range of conditions. Helfie-Backed by science.
Discover the UK's leading SEIS Fund, offering tax-efficient investments in innovative startups. Join thousands of savvy investors and raise capital for your business with SFC Capital.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Information Technology
- Stage:Pre-Seed, Seed
- Geography: United Kingdom, United States, Canada
Investor stats
- Total investments: 377
- Round size: Seed $164k–$2.2M; Pre-Seed $162k–$812k
- Lead/follow: 39% lead, 61% follow
- Last fund: May invest from a new fund soon — raised $1.9M in 2019
Portfolio highlights
- Elaitra — Elaitra’s breast cancer platform includes a Generative LLM for voice-based patient engagement, and a unique AI reading tool that helps doctors read 3D X-Rays. Operating in USA & UK. FDA 510(k) and UK regulator approved.
- Sages — Biodegradeable, non-polluting, low-impact and vibrant dyes extracted from food waste.
- WeFindFlats — Live and work anywhere, without housing worries.
Versant partners with exceptional entrepreneurs to build and fund breakthrough biotechnology companies around the globe.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series A, Series B, Series C
- Geography: United States, Switzerland, Canada
Investor stats
- Total investments: 282
- Round size: Series A $4.7M–$80M; Series B $10M–$105M; Series C $12M–$108M
- Lead/follow: 29% lead, 71% follow
- Last fund: Likely still investing — fund raised in 2023
Portfolio highlights
- Stablix — Stablix is pioneering an entirely new field of targeted protein stabilization (TPS) to bring transformative medicines to patients with unmet medical need.
- Passage Bio — Passage Bio, a genetic medicines company, is changing the future of CNS disorders and transforming the lives of patients and their families.
- Lycia Therapeutics — Lycia Therapeutics is a biotechnology company that focuses on developing technology that utilizes lysosome-targeting chimeras. The company was founded by Carolyn R. Bertozzi in 2019 and is based in San Diego, California, USA.
Anova Capital focus on investment in education, big health and new consumption.
Show more...Investment focus
- Industry: Education, Rental, Travel
- Stage:Series A, Seed
- Geography: China, Australia
Investor stats
- Total investments: 3
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Qukoucai — Qukoucai is an online interactive learning platform for children and children. It focuses on providing customized online personal eloquence courses for 4-12 years old children. It includes a complete closed-loop product of teaching, practice, evaluation and display, and is committed to improving children's eloquence. ability.
- Vantari VR — Virtual Reality for Healthcare
- Woody Library — Woody Library is the first subscription-based book sharing and rental platform in China. In the cabin, you can spend the least amount of money, read the most books, and never again, the book that bought the hand has turned over a few pages and found that it has no long-term collection value.
We're an early-stage venture capital firm investing in technology companies at the Seed and Series A stage.
Show more...Investment focus
- Industry: Software, Developer Tools, Apps
- Stage:Seed, Series A
- Geography: Australia, Canada, United Kingdom
Investor stats
- Total investments: 8
- Round size: Seed $539k–$5M; Series A $5M–$13M
- Lead/follow: 38% lead, 62% follow
Portfolio highlights
- Amaka — Accounting integrations and automation solutions for SMBs. Sync data from POS and e-commerce business apps to Xero, QuickBooks, MYOB and more.
- Riparide — Riparide helps you plan and book your next escape through our Storyteller travel guides. These guides, called Riparide Stories, come packed with unique stays, local adventures and social vibes....
- Lasertrade — Lasertrade is an online marketplace that offers a wide range of medical devices and equipment for the healthcare sector.
Development Bank of Wales is an independent company, providing commercial funding to Welsh SMEs. They invests private and public funds, including EU funds.
Show more...Investment focus
- Industry: Software, Health Care, Biotechnology
- Stage:Seed, Debt Financing
- Geography: United Kingdom, Australia, United States
Investor stats
- Total investments: 221
- Round size: Seed $327k–$3.7M; Debt Financing $18k–$3.7M
- Lead/follow: 59% lead, 41% follow
- Last fund: May invest from a new fund soon — raised $25M in 2018
Portfolio highlights
- Tourhub — tourhub - We collect tours from hundreds of suppliers around the world and provide an easy way for you to search and find those that are of interest.
- Antiverse — Designing biologics for 100 challenging targets
- Hope Macy — Hope Macy is the decisioning and origination layer that modern consumer lenders build on.
HealthCare Ventures is a leading life science venture capital firm investing in pre-clinical or early clinical stage, focused companies with potential to transform patient care.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Pharmaceutical
- Stage:Series B, Series A, Series C
- Geography: United States, Australia, United Kingdom
Investor stats
- Total investments: 103
- Round size: Series A $4.4M–$37M; Series B $10M–$50M; Series C $15M–$44M
- Lead/follow: 17% lead, 83% follow
- Last fund: May invest from a new fund soon — raised $250M in 2010
Portfolio highlights
- Colorescience — Know Better Skin with Colorescience. From mineral sunscreen to clinical skincare products, achieve a clear, even complexion and protect your skin from the damaging effects of the sun and environmental aggressors such as pollution. Shop Now!
- Leap Therapeutics — Leap Therapeutics, Inc., a clinical-stage biopharmaceutical company, is engaged in acquiring and developing novel therapeutics. The company focus is to identify translational-stage molecules in the areas of cell signaling and immuno-oncology.
- Proteostasis Therapeutics — Proteostasis Therapeutics is discovering and developing novel small molecule therapeutics designed to control the body's protein homeostasis, or Proteostasis Network. The Proteostasis Network maintains the body's natural balance of proteins to protect us from numerous diseases. These novel therapies, or Proteostasis Regulators, aredesigned to treat multiple genetic and degenerative disorders associated with deficiencies of the Proteostasis Network, such as emphysema, type II diabetes, Alzheimer's Disease and Huntington's Disease.
Playford Capital is a venture capital arm of South Australian Government Financing Authority specializing in investments in start-ups, early venture, mid venture, late venture stages, and growth capital.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical Device
- Stage:Series A, Series B
- Geography: Australia
Investor stats
- Total investments: 2
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Signostics — Signostics produces Biotech medical devices. Their flagship product, Signos, allows healthcare professionals to use ultrasound in their clinical practice. It offers ultrasound platform technology that clinicians can place in their pocket or wear around their neck like a stethoscope. Just as handheld devices transformed the business world, it isanticipated the Signos will change the way healthcare professionals practice medicine.Signostics was established in Adelaide, Australia in 2005 and expanded into the U.S. in 2008, dedicated to developing fast and affordable pointâ€ofâ€care medical devices. The company launched its first product into the veterinarian market in January 2009 andgained regulatory approvals to enter the human medical device market for the United States, Europe, and Australia in May 2009. Signostics has offices in Palo Alto, California and Adelaide, South Australia.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!The CP Ventures Fund invests in early-stage technology companies that are highly scalable, at the forefront of breakthrough technologies, and driven by the fourth industrial revolution.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Machine Learning
- Stage:Seed, Pre-Seed
- Geography: Australia, United States, India
Investor stats
- Total investments: 58
- Round size: Seed $417k–$3.9M; Pre-Seed $350k–$900k
- Lead/follow: 43% lead, 57% follow
Portfolio highlights
- LeadStory — Watch breaking news from around the world and stay up to date with current events. Follow topics that matter to you from providers you can trust. See whats happening nearby or in places you care about.
- Greenfly — Greenfly's short-form media orchestration software platform captures, collects, organizes & distributes videos & photos to drive fan engagement and boost revenue for sports and entertainment organizations.
- Skylark Labs — Skylark Labs develops continuously evolving and customizable threat detection systems for enhanced physical security. Our clients (CCTV or Drone companies) can customize our proprietary AI solutions at the time of deployment or continuously evolve them if needed after deployment making them preferable to other comparable market solutions.
Learn how we find, fund and support high-impact innovations
Show more...Investment focus
- Industry: Health Care, Medical Device, Biotechnology
- Stage:Grant, Seed, Debt Financing
- Geography: Canada, United States, Australia
Investor stats
- Total investments: 12
- Round size: Grant $100k–$3.3M; Debt Financing $731k–$2M
- Lead/follow: 50% lead, 50% follow
Portfolio highlights
- Hewatele — Hewatele is a social enterprise that provides affordable quality medical oxygen to all needy patients together with its affiliates CPHD and Mediquip Global.
- LegWorks — LegWorks Knees are high-functioning, waterproof, and stable prosthetic devices that fulfill the security needs of low mobility users while still meeting the rugged demands of a highly active amputee.
- Nivi — Nivi is the best digital health chatbot built for whatsapp and rooted in behavioral science. Nivi enables users to take charge of their own health and works with private and public agencies to driver better public health outcomes.
The BridgeLane Group is a privately-owned asset management firm specialising in the agricultural, real estate and innovation sectors. A significant global player in agriculture with a multi-decade record in large scale farming, the Group has a proud history in residential property development, comme
Show more...Investment focus
- Industry: Software, Real Estate, Financial Services
- Stage:Seed, Series A
- Geography: Australia, Germany, United States
Investor stats
- Total investments: 20
- Round size: Seed $673k–$4.2M; Series A $3M–$6M
- Lead/follow: 35% lead, 65% follow
Portfolio highlights
- MadeComfy — Award-winning Airbnb management service in Australia and New Zealand. MadeComfy is a selected official partner of Airbnb. Find out how we earn you higher returns with short-term rentals.
- Futurerent — Futurerent is a tool that offers solutions to residential property investors for investment capital and cashflow needs.
- Evrima Technologies — Our clinical trial recruitment and management services put participants first. Trusted, timely clinical trial results are a good thing - for everybody.
Archangel is an early stage venture capital fund based in Australia. We work with great founders and investors to build game changing companies together.
Show more...Investment focus
- Industry: Software, SaaS, Artificial Intelligence
- Stage:Seed, Pre-Seed, Series A
- Geography: Australia, United States, Philippines
Investor stats
- Total investments: 61
- Round size: Seed $750k–$4.3M; Pre-Seed $100k–$1.5M; Series A $3.3M–$22M
- Lead/follow: 20% lead, 80% follow
Portfolio highlights
- Mutinex — Discover how Mutinex helps businesses optimize marketing decisions with data-driven insights and AI-powered solutions.
- Modo — Declutter your mind with our app to boost your mental wellbeing and productivity. modo helps you be present in the moment and focus on what matters most.
- Vouch — Vouch allows you to collect, edit & share authentic videos with a single link. Capture customer video testimonials, employee feedback, win-loss reports & more.
Sirius Capital is a venture capital firm in China that invests in technology companies.
Show more...Investment focus
- Industry: Artificial Intelligence, Robotics, Video
- Stage:Series A, Seed, Angel
- Geography: China, Australia
Investor stats
- Total investments: 9
- Round size: Series A $7M–$50M
- Lead/follow: 11% lead, 89% follow
Portfolio highlights
- Vantari VR — Virtual Reality for Healthcare
- Zenbot — Zenbot is a high-growth startup specializing in embodied intelligence infrastructure.
- Kuanfen Technology Realcome — Kuanfen Technology Realcome is a brand of AI virtual bloggers that focuses on the use of various AI technologies.
A tradition of fostering strong global links in teaching and research and programmes of national significance and international quality.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical Device
- Stage:Seed
- Geography: Australia
Investor stats
- Total investments: 1
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Ferronova — Ferronova is a medical device company that offers imaging and surgery products.
Starfish Ventures is an Australian venture capital firm focused on information technology, life sciences, and clean technology companies.
Show more...Investment focus
- Industry: Software, Enterprise Software, Internet
- Stage:Series A, Series B
- Geography: United States, Australia, Philippines
Investor stats
- Total investments: 53
- Round size: Series A $2M–$6.6M; Series B $2.5M–$18M
- Lead/follow: 51% lead, 49% follow
- Last fund: May invest from a new fund soon — raised $134M in 2008
Portfolio highlights
- Aktana — Build stronger relationships with HCPs using Aktana's artificial intelligence (AI) platform for life sciences to optimize omnichannel engagement.
- DesignCrowd — Crowdsourced logo, freelance graphic and web design at DesignCrowd. 1,328,201 freelance designers compete to create amazing designs for your business. Start Today!
- Marani — Marani helps maternity providers quickly identify and manage maternal and fetal risk as well as empowering moms to have healthier pregnancies.
Right Click Capital - Australian Venture Capital Firm
Show more...Investment focus
- Industry: Software, SaaS, Information Technology
- Stage:Seed, Series A
- Geography: Australia, Singapore, United States
Investor stats
- Total investments: 61
- Round size: Seed $200k–$3.6M; Series A $3.3M–$16M
- Lead/follow: 25% lead, 75% follow
- Last fund: May invest from a new fund soon — last raise in 2017
Portfolio highlights
- black.ai — Build smarter spaces with Black.ai
- Tability — Automate the boring parts of OKRs to cut the waste and spend more time doing what really matters.
- Nomad Atomics — At Nomad Atomics, we develop innovative quantum sensors to solve outstanding problems in mining, underground resources and navigation
UniSA Ventures is the technology commercialisation and investment management company of the University of South Australia (UniSA).
Show more...Investment focus
- Industry: Software, Health Care, Biotechnology
- Stage:Seed
- Geography: Australia
Investor stats
- Total investments: 2
- Lead/follow: 50% lead, 50% follow
Portfolio highlights
- Ferronova — Ferronova is a medical device company that offers imaging and surgery products.
- Framework — Framework is an all-in-one tool for teams and individuals. You can use Framework to do anything from project management, sales pipeline & customer relationship management, wiki & documentation, team communication (team chat, voice & video calls), and meeting scheduling.Framework can help organize your ideas with nodes. A node is apiece of information and each node is connected and related to other nodes.
Skip Capital is a private investment fund investing in technology and infrastructure
Show more...Investment focus
- Industry: Software, Artificial Intelligence, SaaS
- Stage:Seed, Series A, Series B
- Geography: Australia, United States, Canada
Investor stats
- Total investments: 80
- Round size: Seed $1.3M–$9M; Series A $4M–$50M; Series B $10M–$100M
- Lead/follow: 26% lead, 74% follow
Portfolio highlights
- Reejig — At Reejig, we believe in zero wasted potential in people and in business – and that starts with harnessing the skills you have within your organisation. Our workforce intelligence platform provides 100% visibility of your people’s skills, potential, passions and experiences, creating a powerful central nervous system for all talent decisions.Powered by the world’s first independently audited Ethical Talent AI engine, Reejig generates the intelligence to instantly fill roles, track retention risks, mobilise talent to opportunities, pivot talent for reskilling and much more. Plus, we give you the power to ‘nudge’ people to new career opportunities, taking your engagement with internal and external talent to the next level. Put simply, we make workforce agility a reality.Reejig is trusted and used by some of the largest and most complex organisations including Woolworths, KPMG, NSW Government, John Holland, MYOB and UTS, and together we are creating a world where everyone can reach their full potential at work. It’s what we call zero-wasted potential in people and in business.
- Brighte — Brighte makes solar, battery and home improvements affordable for Aussies with easy finance and a network of trusted tradies.
- WORK180 — WORK180 is a global jobs network that operates at the forefront of a new workplace revolution. Our function is twofold.As an advocate for working women, we provide job applicants with a transparent directory of endorsed employers who support diversity, inclusion and equality.We share information around pay equity, flexible working, paidparental leave, equal opportunities and a range of other important criteria. Before an employer comes on board, we put them through a pre-screening process and on average, about 80% of companies who apply to work with us, pass our criteria.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!A multi-stage investment fund focused on Consumer, Enterprise, Fintech, Frontier, Healthcare, & PropTech
Show more...Investment focus
- Industry: Software, Health Care, Machine Learning
- Stage:Seed, Series A
- Geography: United States, Colombia, India
Investor stats
- Total investments: 85
- Lead/follow: no public data
Portfolio highlights
- Hadean — Hadean are a venture backed tech startup providing the most simple and secure platform for cloud native development. Intuitive and developer friendly, the Hadean Platform provides a friction free route to a cloud-native infrastructure. It lets you write applications once and deploy anywhere, taking care of setup, configuration, scaling, securityand more.Hadean have developed two flagship applications. Aether Engine provides distributed load balancing for agent-based simulations, while Muxer is a network model that utilises distributed edge networks. The result is spatial simulations of unparalleled size and complexity, where thousands of concurrent users can join and interact. Hadean have found traction in gaming, healthcare, virtual events and defence with industry leading companies such as Microsoft, Minecraft and CAE.
- MarketForce — MarketForce connects Africa’s informal retail outlets and consumers directly to suppliers of consumer goods and financial services by digitizing orders, delivery, and payments with the aim of solving the last mile distribution challenge.
- Dayta AI — SaaS Shopper Analytics - Cyclops presents you insightful data like shopper demographics, bahavioral metrics and many more. Drive more sales and traffic with AI now!
Khosla Ventures is a venture capital firm that invests in early- to late-stage companies across sectors like AI, healthcare, sustainability, and consumer technology. It manages multiple funds, focusing on startups with innovative technologies or business models. The firm primarily targets sectors like AI, climate tech, digital health, and medtech,offering strategic support to help build long-lasting companies.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Health Care
- Stage:Series A, Series B, Seed
- Geography: United States, India, United Kingdom
Investor stats
- Total investments: 1085
- Round size: Seed $2M–$17M; Series A $5.5M–$44M; Series B $10M–$100M
- Lead/follow: 39% lead, 61% follow
- Last fund: Likely still investing — raised $557M in 2022
Portfolio highlights
- Fundbox — Fundbox offers fast, easy access to business financing, up to $150,000. Learn how our line of credit and term loan options can unlock growth for your business.
- Even — Even is a health tech company and healthcare provider that partners directly with the top hospitals in the country to offer you unlimited diagnostics, consultations, and 50 lakh worth of hospitalisations all with one monthly subscription cost.
- Loop — Loop Health is bringing ease and choice to patients seeking major medical treatments. We've brought together family physicians, top specialists, and leading hospitals in Pune – to provide options, transparency, and ease to patients and their families. Loop Coordinators help patients match with a doctor, compare treatment costs, get secondopinions, and complete admission formalities – removing the stress and making lives easier for the patient and their families.
FundWA is a Western Australian venture capital fund that invests in technology-enabled innovative businesses in Western Australia.
Show more...Investment focus
- Industry: Medical, Health Care, Manufacturing
- Stage:Seed, Series A
- Geography: Australia
Investor stats
- Total investments: 7
- Lead/follow: 57% lead, 43% follow
Portfolio highlights
- Enzide — Plastic without Pollution: What if there was a way to make plastic harmless and go away when it's no longer needed? With Australia's best scientists we’ve developed super enzyme technology that makes this possible.
- personr — Single source of truth for AML compliance
- Hola Health — 24 hour online doctors & GP consults via telehealth appointments in 15 minutes. Get instant scripts online, medical certificate online anywhere in Australia.
Investing in the deep science and technology that can propel humanity towards a radically better future.
Show more...Investment focus
- Industry: Biotechnology, Software, Artificial Intelligence
- Stage:Series A, Series B, Seed
- Geography: United States, United Kingdom, Canada
Investor stats
- Total investments: 250
- Round size: Seed $1M–$11M; Series A $6.2M–$50M; Series B $8M–$110M
- Lead/follow: 44% lead, 56% follow
Portfolio highlights
- Scopely — Scopely is a global interactive entertainment and mobile-first games company, home to many top-grossing, award-winning franchises including “Star Trek™ Fleet Command,” “MARVEL Strike Force,” “Scrabble® GO,” “WWE Champions” and “Yahtzee® With Buddies,” among others. Scopely creates, publishes and live-operates immersive games that empower adirected-by-consumer™ experience. Founded in 2011, Scopely is fueled by a world-class team and a proprietary technology platform Playgami that supports one of the most diversified portfolios in the mobile games industry. Recognized multiple times as one of Fast Company’s “World’s Most Innovative Companies,” Scopely is a multi-billion-dollar business due to its ability to create long-lasting game experiences that players enjoy for years. Scopely has global operations across 17 markets (Asia-Pacific - Bangalore, Seoul, Shanghai, Singapore, Tokyo; EMEA - Barcelona, Dublin, Helsinki, Kyiv, London, Seville, Tel Aviv; North America - Boston, Boulder, Culver City, Mountain View, San Francisco), with additional game studio partners across four continents. For more information, visit www.scopely.com.
- Synthace — The Synthace Experiment Platform lets you design powerful experiments, run them in your lab, & gather automatically structured datasets. No code necessary.
- Amper Music — Amper is an AI music composition company that develops tools for content creators of all kinds. Learn about our new enterprise platform, Score, as well as our creator API.
Microsoft for Startups is a global program designed to help startups scale with free access to Azure cloud and a streamlined path into selling alongside Microsoft and our vast partner ecosystem.
Show more...Investment focus
- Industry: Software, Information Technology, SaaS
- Stage:Seed, Pre-Seed
- Geography: United States, India, Canada
Investor stats
- Total investments: 71
- Lead/follow: no public data
Portfolio highlights
- VitVio — VitVio is a platform built around AI and computer vision with the goal of improving efficiency and quality of care in operating rooms.
- UniPay — UniPay is an eCommerce platform for infrastructure and industry-lacking regions that offers 5 products that enable trust, promote transparency, and enforce accountability.
- Emission Sentri — Drive emission management and reduction with insights
SOSV is a global, deep tech venture capital firm that operates the HAX and IndieBio startup development programs focused on human and planetary health. SOSV invests $500,000 in startups at their inception as they onboard either HAX or IndieBio for a 4-6 month period designed to accelerate the raise of their next institutional round. SOSV joins thelater rounds of HAX and IndieBio graduates. HAX, based in a 35,000 sq ft facility in Newark, NJ, is equipped with machine tools, 3D printers, chemical, electrical and mechanical engineering labs, as well as on-staff engineering and design experts. SOSV's IndieBio has locations in NYC and San Francisco, both of which offer extensive services and facilities to founders including on-site BSL-2 labs, well equipped lab benches and hoods, and advanced lab equipment, such as chromatography equipment.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Software
- Stage:Seed, Convertible Note, Pre-Seed
- Geography: United States, India, United Kingdom
Investor stats
- Total investments: 1482
- Lead/follow: no public data
Portfolio highlights
- MixRift — MIXRIFT - game developers specialized in Mixed Reality
- unspun — From 3D scan to perfect fitting custom jeans. unspun makes each pair of jeans unique to your actual body and design. On a mission to reduce global carbon emissions by 1%. As seen in Fast Company's World Changing Ideas, Time's Best Inventions, and PopSci's Best of What's New. Welcome to the future of apparel.
- Mesa Quantum — Unlock the potential of chip-scale quantum sensing for enhanced Position, Navigation, And Timing capabilities. Explore Mesa Quantum's practical solutions.
A fund focused on delivering long term capital growth whilst increasing the wellbeing of Australians by investing in the future healthcare needs of Australians.
Show more...Investment focus
- Industry: Health Care, Medical Device
- Stage:Series A
- Geography: Australia
Investor stats
- Total investments: 1
- Lead/follow: 100% lead, 0% follow
Portfolio highlights
- Oli — Baymatob is an AI-guided solution to improve health outcomes for mothers and their babies.
Monash Ventures is a newly launched initiative from Monash University that serves as the university's dedicated venture and investment arm. Its purpose is to finance and nurture spinout companies, commercialise research outcomes—particularly in the healthcare sector—and support early-stage research commercialisation.
Show more...Investment focus
- Industry: Medical, Health Care, Biotechnology
- Stage:Pre-Seed
- Geography: Australia, Philippines, United States
Investor stats
- Total investments: 3
- Lead/follow: 100% lead, 0% follow
Portfolio highlights
- Fyton Bio — FytonBio is a privately held, preclinical-stage biopharmaceutical company specializing in biotechnology research. Their core mission is to achieve functional cures for autoimmune and inflammatory diseases by deleting pathogenic immune cells. The company focuses on developing monoclonal antibodies capable of highly specific depletion of such cellsto durably alter disease progression.
- Myostellar — Myostellar is creating a first-in-class, highly differentiated biologic therapy that stimulates muscle stem cells to promote muscle regeneration with no fibrosis.
- Remagine Labs — Remagine Labs is revolutionizing healthcare with a bluetooth-connected, wearable electro-pharmaceutical that provide patient-centered care and consistent drug administration, giving healthcare customers peace of mind all over the world.
SPRIM Global Investments is a privately held company established in 2008 after SPRIM Consulting & Services expanded globally.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical Device
- Stage:Series A, Debt Financing
- Geography: France, Australia, United States
Investor stats
- Total investments: 13
- Round size: Series A $10M–$22M; Debt Financing $500k–$26M
- Lead/follow: 85% lead, 15% follow
Portfolio highlights
- NinaMED — NinaMED is a healthcare and medical solutions company associated with medical services and technology-enabled healthcare solutions.
- RheumaGen — At RheumaGen, we aim to create a unique and revolutionary therapeutic pathway to cure autoimmune diseases at their source.
- Doron Therapeutics — Doron Therapeutics is a clinical-stage biotechnology company that has developed intra-articular biologic drugs derived from placental tissue and consistently delivers a host of beneficial growth factors with potent anti-inflammatory, tissue-protective, and regenerative capabilities pivotal to the progressive and degenerative disease ofosteoarthritis.
Progressive Technology To The People
Show more...Investment focus
- Industry: Bitcoin, FinTech, Medical
- Stage:Seed
- Geography: Australia, United States
Investor stats
- Total investments: 2
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Neurode — Drug free, non-invasive treatment of ADHD
- Purse — The biggest challenge to Bitcoin commerce is the lack of consumer incentive to spend. Purse generates this incentive in the form of 15% discounts on Amazon. Buyers can purchase bitcoins with a credit card as easily as checking out on Amazon, thus solving the last mile problem.
Medical Device VC funding in Australia at a glance
Stats across 136 deals from 123 investors.
Access all 123 VC funds in Australia Medical Device startups.
Open ListFAQ
Is Shizune data fresh/accurate?
Shizune has monitored hundreds of funding sources since 2020.
Our investor database is updated every day, so investor data is always fresh.
All metrics are calculated from confirmed public rounds, so the data is accurate.
Can I download investor list?
To download the Medical Device VC Funds in Australia investor list, create a Shizune account. This investor list will be added to your saved investors and available for download in the export section.
You can also enrich the investor list with investor emails, phones, LinkedIns, and other contact data.
Can I access investor database?
To access all 123 VC funds investing in Australia Medical Device startups and 48,091+ more investors, create a Shizune account.
Shizune has a database of 48,091 investors. Our investor database is fresh and updated daily.
The Shizune investor database has information on investor investment focus, investor contact data, and full investor portfolio since 2020.
You can enrich with email and download the data.
Does Shizune have investor emails and contacts?
Shizune enriches investors with contact data that includes: email, phones, LinkedIn, socials, website, and others.
To guarantee the highest discovery rate, we search across 20+ contact search tools.
To maximize delivery rate and reduce bounce rate, we validate emails.
You can enrich your investor list with Shizune. Download it too.
What is Shizune?
Shizune is a 48,091 investor database updated daily.
With Shizune you can:
- browse the database
- use smart matching
- enrich with emails
- download
All you need to find investors for your startup.
Who is Shizune for?
Shizune is built for startup founders by startup founders.
If you are looking for funding for your startup, try the Shizune database — we have investors for every stage, industry, and country.
Is Shizune free?
Shizune is free forever. You can search and browse investors for free.
Email search and export are paid features.
For full info, visit our pricing.
Who built Shizune?
Shizune is built by founders with the goal of helping all founders raise funding no matter where they are.
Contact 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!